Cargando…
Discovery of a Potent, Long‐Acting, and CNS‐Active Inhibitor (BIA 10‐2474) of Fatty Acid Amide Hydrolase
Fatty acid amide hydrolase (FAAH) can be targeted for the treatment of pain associated with various medical conditions. Herein we report the design and synthesis of a novel series of heterocyclic‐N‐carboxamide FAAH inhibitors that have a good alignment of potency, metabolic stability and selectivity...
Autores principales: | Kiss, László E., Beliaev, Alexandre, Ferreira, Humberto S., Rosa, Carla P., Bonifácio, Maria João, Loureiro, Ana I., Pires, Nuno M., Palma, P. Nuno, Soares‐da‐Silva, Patrício |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582431/ https://www.ncbi.nlm.nih.gov/pubmed/30113139 http://dx.doi.org/10.1002/cmdc.201800393 |
Ejemplares similares
-
Preclinical pharmacological evaluation of the fatty acid amide hydrolase inhibitor BIA 10‐2474
por: Bonifácio, Maria‐João, et al.
Publicado: (2020) -
Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10‐2474: A Double‐Blind, Randomized, Placebo‐Controlled Study in Healthy Volunteers
por: Rocha, José‐Francisco, et al.
Publicado: (2021) -
What failed BIA 10–2474 Phase I clinical trial? Global speculations and recommendations for future Phase I trials
por: Kaur, Rimplejeet, et al.
Publicado: (2016) -
2474. Emergence of Candida auris in Michigan
por: McNamara, Sara E, et al.
Publicado: (2023) -
Discovery of Uracil Derivatives as Potent Inhibitors of Fatty Acid Amide Hydrolase
por: Qiu, Yan, et al.
Publicado: (2016)